Teva Pharmaceutical's Annual Meeting Results

Summary

At Teva Pharmaceutical Industries Limited's Annual Meeting held on June 5, 2025, shareholders elected new directors and approved various compensation policies. Chen Lichtenstein, Amir Elstein, Roberto A. Mignone, Dr. Perry D. Nisen, and Dr. Tal Zaks were elected to the Board with significant support. Shareholders also approved the compensation for named executive officers and amendments to the Compensation Policy, terms of office and employment of Executive Officers and Directors, and the President and Chief Executive Officer. Additionally, amendments to the compensation for non-employee Directors and the non-executive Chairman of the Board were approved. Shareholders further appointed Kesselman & Kesselman as the independent registered public accounting firm until the 2026 annual meeting.